Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway

Human Molecular Genetics

Volumn 14, Issue 20, 2005, Pages 3003-3011

  Berger, Zdenek ^a,b   Ttofi, Evangelia K ^a,b   Michel, Claire H ^b   Pasco, Matthieu Y ^b   Tenant, Sean ^b   Rubinsztein, David C ^a   O'Kane, Cahir J ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; POLYGLUTAMINE; WNT PROTEIN;

ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DROSOPHILA; DRUG SPECIFICITY; DRUG TARGETING; ENZYME INHIBITION; EYE TOXICITY; GENE DUPLICATION; GENE OVEREXPRESSION; HUNTINGTON CHOREA; IN VIVO STUDY; NONHUMAN; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PRIORITY JOURNAL; PROTEIN AGGREGATION; SURVIVAL; WESTERN BLOTTING;

ANIMALS; DROSOPHILA; DROSOPHILA PROTEINS; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; PEPTIDES; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; TRINUCLEOTIDE REPEAT EXPANSION; WNT PROTEINS;

EID: 27544497472     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi331     Document Type: Article

References (57)

1. Gusella, J.F. and MacDonald, M.E. (2000) Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease. Nat. Rev. Neurosci., 1, 109-115.
2. Brown, L.Y. and Brown, S.A. (2004) Alanine tracts: The expanding story of human illness and trinucleotide repeats. Trends Genet., 20, 51-58.
3. Brais, B., Bouchard, J.P., Xie, Y.G., Rochefort, D.L., Chretien, N., Tome, F.M., Lafreniere, R.G., Rommens, J.M., Uyama, E., Nohira, O. et al. (1998) Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat. Genet., 18, 164-167.
4. Carmichael, J., Sugars, K.L., Bao, Y.P. and Rubinsztein, D.C. (2002) Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation. J. Biol. Chem., 277, 33791-33798.
5. Wood, N.I. and Morton, A.J. (2003) Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutation. Brain Res. Bull., 61, 375-383.
6. Pilcher, H.R. (2003) Drug research: The ups and downs of lithium. Nature, 425, 118-120.
7. Wood, A.J., Goodwin, G.M., De Souza, R. and Green, A.R. (1986) The pharmacokinetic profile of lithium in rat and mouse; an important factor in psychopharmacological investigation of the drug. Neuropharmacology, 25, 1285-1288.
8. Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, F., Easton, D.F., Duden, R., O'Kane, C.J. et al. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet., 36, 585-595.
9. Marsh, J.L. and Thompson, L.M. (2004) Can flies help humans treat neurodegenerative diseases? Bioessays, 26, 485-496.
10. Jackson, G.R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P.W., MacDonald, M.E. and Zipursky, S.L. (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron, 21, 633-642.
11. Steffan, J.S., Agrawal, N., Pallos, J., Rockabrand, E., Trotman, L.C., Slepko, N., Illes, K., Lukacsovich, T., Zhu, Y.Z., Cattaneo, E. et al. (2004) SUMO modification of Huntingtin and Huntington's disease pathology. Science, 304, 100-104.
12. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. et al. (2001) Historic deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature, 413, 739-743.
13. Rubinsztein, D.C. and Carmichael, J. (2003) Huntington's disease: molecular basis of neurodegeneration. Expert Rev. Mol. Med, 5, 1-21.
14. Phiel, C.J. and Klein, P.S. (2001) Molecular targets of lithium action. Annu. Rev. Pharmacol. Toxicol., 41, 789-813.
15. Marsh, J.L., Walker, H., Theisen, H., Zhu, Y.Z., Fielder, T., Purcell, J. and Thompson, L.M. (2000) Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet., 9, 13-25.
16. Peters, M.F., Nucifora, F.C., Jr, Kushi, J., Seaman, H.C., Cooper, J.K., Herring, W.J., Dawson, V.L., Dawson, T.M. and Ross, C.A. (1999) Nuclear targeting of mutant Huntingtin increases toxicity. Mol. Cell. Neurosci., 14, 121-128.
17. Gould, T.D., Chen, G. and Manji, H.K. (2004) In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3. Neuropsychopharmacology, 29, 32-38.
18. Kazemi-Esfarjani, P. and Benzer, S. (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science, 287, 1837-1840.
19. Greaves, S., Sanson, B., White, P. and Vincent, J.P. (1999) A screen for identifying genes interacting with armadillo, the Drosophila homolog of beta-catenin. Genetics, 153, 1753-1766.
20. Moon, R.T., Bowerman, B., Boutros, M. and Perrimon, N. (2002) The promise and perils of Wnt signaling through beta-catenin. Science, 296, 1644-1646.
21. Klein, P.S. and Melton, D.A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA, 93, 8455-8459.
22. Hedgepeth, C.M., Conrad, L.J., Zhang, J., Huang, H.C., Lee, V.M. and Klein, P.S. (1997) Activation of the Wnt signaling pathway: A molecular mechanism for lithium action. Dev. Biol., 185, 82-91.
23. Stambolic, V., Ruel, L. and Woodgett, J.R. (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol., 6, 1664-1668.
24. Dokucu, M.E., Yu, L. and Taghert, P.H. (2005) Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila. Neuropsychopharmacology, (in press).
25. Mudher, A., Shepherd, D., Newman, T.A., Mildren, P., Jukes, J.P., Squire, A., Mears, A., Drummond, J.A., Berg, S., MacKay, D. et al. (2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol. Psychiatry, 9, 522-530.
26. Padiath, Q.S., Paranjpe, D., Jain, S. and Sharma, V.K. (2004) Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks. Chronobiol. Int., 21, 43-55.
27. Bhat, R.V., Budd Haeberlein, S.L. and Avila, J. (2004) Glycogen synthase kinase 3: A drug target for CNS therapies. J. Neurochem., 89, 1313-1317.
28. Cohen, P. and Goedert, M. (2004) GSK3 inhibitors: Development and therapeutic potential. Nat. Rev. Drug Discov., 3, 479-487.
29. Bourouis, M. (2002) Targeted increase in shaggy activity levels blocks wingless signaling. Genesis, 34, 99-102.
30. Papadopoulou, D., Bianchi, M.W. and Bourouis, M. (2004) Functional studies of shaggy/glycogen synthase kinase 3 phosphorylation sites in Drosophila melanogaster. Mol. Cell. Biol., 24, 4909-4919.
31. Pai, L.M., Orsulic, S., Bejsovec, A. and Peifer, M. (1997) Negative regulation of Armadillo, a Wingless effector in Drosophila. Development, 124, 2255-2266.
32. van de Wetering, M., Cavallo, R., Dooijes, D., van Beest, M., van Es, J., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A. et al. (1997) Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell, 88, 789-799.
33. Peifer, M., Sweeton, D., Casey, M. and Wieschaus, E. (1994) Wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo. Development, 120, 369-380.
34. Tomlinson, A., Strapps, W.R. and Heemskerk, J. (1997) Linking Frizzled and Wnt signaling in Drosophila development. Development, 124, 4515-4521.
35. Ruel, L., Stambolic, V., Ali, A., Manoukian, A.S. and Woodgett, J.R. (1999) Regulation of the protein kinase activity of Shaggy(Zeste-white3) by components of the wingless pathway in Drosophila cells and embryos. J. Biol. Chem., 274, 21790-21796.
36. Jackson, G.R., Wiedau-Pazos, M., Sang, T.K., Wagle, N., Brown, C.A., Massachi, S. and Geschwind, D.H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron, 34, 509-519.
37. Kazemi-Esfarjani, P. and Benzer, S. (2002) Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1. Hum. Mol. Genet., 11, 2657-2672.
38. Warrick, J.M., Chan, H.Y., Gray-Board, G.L., Chai, Y., Paulson, H.L. and Bonini, N.M. (1999) Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet., 23, 425-428.
39. Kim, W.Y., Fayazi, Z., Bao, X., Higgins, D. and Kazemi-Esfarjani, P. (2005) Evidence for sequestration of polyglutamine inclusions by Drosophila myeloid leukemia factor. Mol. Cell. Neurosci, 29, 536-544.
40. Hay, D.G., Sathasivam, K., Tobaben, S., Stahl, B., Marber, M., Mestril, R., Mahal, A., Smith, D.L., Woodman, B. and Bates, G.P. (2004) Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum. Mol. Genet., 13, 1389-1405.
41. Sittler, A., Lurz, R., Lueder, G., Priller, J., Lehrach, H., Hayer-Hartl, M.K., Hartl, F.U. and Wanker, E.E. (2001) Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. Hum. Mol. Genet., 10, 1307-1315.
42. Smith, D.F. (1978) Lithium chloride toxicity and pharmacodynamics in inbred mice. Acta Pharmacol. Toxicol. (Copenh), 43, 51-54.
43. Nonaka, S. and Chuang, D.M. (1998) Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport, 9, 2081-2084.
44. Wei, H., Qin, Z.H., Senatorov, V.V., Wei, W., Wang, Y., Qian, Y. and Chuang, D.M. (2001) Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience, 106, 603-612.
45. McQuade, R., Leitch, M.M., Gartside, S.E. and Young, A.H. (2004) Effect of chronic lithium treatment on glucocorticoid and 5-HT1A receptor messenger RNA in hippocampal and dorsal raphe nucleus regions of the rat brain. J. Psychopharmacol., 18, 496-501.
46. Hamamura, T., Lee, Y., Ohashi, K., Fujiwara, Y., Miki, M., Suzuki, H. and Kuroda, S. (2000) A low dose of lithium chloride selectively induces Fos protein in the central nucleus of the amygdala of rat brain. Prog. Neuropsychopharmacol. Biol. Psychiatry, 24, 285-294.
47. Camus, M., Hennere, G., Baron, G., Peytavin, G., Massias, L., Mentre, F. and Farinotti, R. (2003) Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity. Eur. J. Clin. Pharmacol., 59, 583-587.
48. Manji, H.K., Moore, G.J. and Chen, G. (1999) Lithium at 50: Have the neuroprotcctive effects of this unique cation been overlooked? Biol. Psychiatry, 46, 929-940.
49. Bao, Y.P., Cook, L.J., O'Donovan, D., Uyama, E. and Rubinsztein, D.C. (2002) Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy. J. Biol. Chem., 277, 12263-12269.
50. Brand, A.H. and Perrimon, N. (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development, 118, 401-415.
51. Lin, M.H., Bour, B.A., Abmayr, S.M. and Storti, R.V. (1997) Ectopic expression of MEF2 in the epidermis induces epidermal expression of muscle genes and abnormal muscle development in Drosophila. Dev. Biol., 182, 240-255.
52. Freeman, M. (1996) Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell, 87, 651-660.
53. Bonini, N.M., Bui, Q.T., Gray-Board, G.L. and Warrick, J.M. (1997) The Drosophila eyes absent gene directs ectopic eye formation in a pathway conserved between flies and vertebrates. Development, 124, 4819-4826.
54. Therrien, M., Wong, A.M., Kwan, E. and Rubin, G.M. (1999) Functional analysis of CNK in RAS signaling. Proc. Natl Acad. Sci. USA, 96, 13259-13263.
55. Perrimon, N. and Mahowald, A.P. (1987) Multiple functions of segment polarity genes in Drosophila. Dev. Biol., 119, 587-600.
56. Wieschaus, E. and Riggleman, R. (1987) Autonomous requirements for the segment polarity gene armadillo during Drosophila embryogenesis. Cell, 49, 177-184.
57. Franceschini, N. and Kirschfeld, K. (1971) Pseudopupil phenomena in the compound eye of Drosophila. Kybernetik, 9, 159-182.